{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:42:28Z","timestamp":1793122948619,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["779295"],"award-info":[{"award-number":["779295"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["767015"],"award-info":[{"award-number":["767015"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41590-020-00840-x","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T06:03:23Z","timestamp":1607061803000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":511,"title":["Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0965-3863","authenticated-orcid":false,"given":"Ioanna-Evdokia","family":"Galani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Lampropoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5832-4014","authenticated-orcid":false,"given":"Vasiliki","family":"Triantafyllia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Manioudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Pavlos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Koukaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2022-2949","authenticated-orcid":false,"given":"Paraskevi C.","family":"Fragkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Panou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Rapti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Koltsida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Mentis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Koulouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsiodras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Koutsoukou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Andreakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"840_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev.micro.55.1.255","volume":"55","author":"GC Sen","year":"2001","unstructured":"Sen, G. C. Viruses and interferons. Annu. Rev. Microbiol. 55, 255\u2013281 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"840_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"840_CR3","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720 (2020).","journal-title":"N. Engl. J. Med."},{"key":"840_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"840_CR5","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R Wolfel","year":"2020","unstructured":"Wolfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469 (2020).","journal-title":"Nature"},{"key":"840_CR6","doi-asserted-by":"publisher","first-page":"m1443","DOI":"10.1136\/bmj.m1443","volume":"369","author":"S Zheng","year":"2020","unstructured":"Zheng, S. et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. Brit. Med. J. 369, m1443 (2020).","journal-title":"Brit. Med. J."},{"key":"840_CR7","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1146\/annurev.pathmechdis.3.121806.154316","volume":"3","author":"JK Taubenberger","year":"2008","unstructured":"Taubenberger, J. K. & Morens, D. M. The pathology of influenza virus infections. Annu. Rev. Pathol. 3, 499\u2013522 (2008).","journal-title":"Annu. Rev. Pathol."},{"key":"840_CR8","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(17)30129-0","volume":"390","author":"C Paules","year":"2017","unstructured":"Paules, C. & Subbarao, K. Influenza. Lancet 390, 697\u2013708 (2017).","journal-title":"Lancet"},{"key":"840_CR9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1473-3099(09)70069-6","volume":"9","author":"J Lessler","year":"2009","unstructured":"Lessler, J. et al. Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect. Dis. 9, 291\u2013300 (2009).","journal-title":"Lancet Infect. Dis."},{"key":"840_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"840_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu, C. et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern. Med. 180, 934\u2013943 (2020).","journal-title":"JAMA Intern. Med."},{"key":"840_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang, X. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 8, 475\u2013481 (2020).","journal-title":"Lancet Respir. Med"},{"key":"840_CR13","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.immuni.2017.04.025","volume":"46","author":"IE Galani","year":"2017","unstructured":"Galani, I. E. et al. Interferon-\u03bb mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity 46, 875\u2013890.e6 (2017).","journal-title":"Immunity"},{"key":"840_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms4864","volume":"5","author":"S Davidson","year":"2014","unstructured":"Davidson, S., Crotta, S., McCabe, T. M. & Wack, A. Pathogenic potential of interferon \u03b1\u03b2 in acute influenza infection. Nat. Commun. 5, 3864 (2014).","journal-title":"Nat. Commun."},{"key":"840_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.coi.2018.10.007","volume":"56","author":"E Andreakos","year":"2019","unstructured":"Andreakos, E., Zanoni, I. & Galani, I. E. \u03bb interferons come to light: dual function cytokines mediating antiviral immunity and damage control. Curr. Opin. Immunol. 56, 67\u201375 (2019).","journal-title":"Curr. Opin. Immunol."},{"key":"840_CR16","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045 (2020).","journal-title":"Cell"},{"key":"840_CR17","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"840_CR18","doi-asserted-by":"crossref","unstructured":"World Health Organization. Clinical management of COVID-19: interim guidance, 27 May 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/332196 (2020).","DOI":"10.15557\/PiMR.2020.0004"},{"key":"840_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/thorax.58.5.377","volume":"58","author":"WS Lim","year":"2003","unstructured":"Lim, W. S. et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58, 377\u2013382 (2003).","journal-title":"Thorax"},{"key":"840_CR20","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2016.03.046","volume":"165","author":"VA Rathinam","year":"2016","unstructured":"Rathinam, V. A. & Fitzgerald, K. A. Inflammasome complexes: emerging mechanisms and effector functions. Cell 165, 792\u2013800 (2016).","journal-title":"Cell"},{"key":"840_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.4VMR1114-555R","volume":"98","author":"IE Galani","year":"2015","unstructured":"Galani, I. E. & Andreakos, E. Neutrophils in viral infections: current concepts and caveats. J. Leukoc. Biol. 98, 557\u2013564 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"840_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2020.06.017","volume":"53","author":"N Mangalmurti","year":"2020","unstructured":"Mangalmurti, N. & Hunter, C. A. Cytokine storms: understanding COVID-19. Immunity 53, 19\u201325 (2020).","journal-title":"Immunity"},{"key":"840_CR23","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Invest."},{"key":"840_CR24","doi-asserted-by":"publisher","first-page":"e12421","DOI":"10.15252\/emmm.202012421","volume":"12","author":"T Liu","year":"2020","unstructured":"Liu, T. et al. The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol. Med. 12, e12421 (2020).","journal-title":"EMBO Mol. Med."},{"key":"840_CR25","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","volume":"19","author":"R Channappanavar","year":"2016","unstructured":"Channappanavar, R. et al. Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice. Cell Host Microbe 19, 181\u2013193 (2016).","journal-title":"Cell Host Microbe"},{"key":"840_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706\u2013712 (2020).","journal-title":"Science"},{"key":"840_CR27","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, 712\u2013717 (2020).","journal-title":"Science"},{"key":"840_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.it.2012.01.004","volume":"33","author":"BX Wang","year":"2012","unstructured":"Wang, B. X. & Fish, E. N. The yin and yang of viruses and interferons. Trends Immunol. 33, 190\u2013197 (2012).","journal-title":"Trends Immunol."},{"key":"840_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.chom.2020.07.005","volume":"28","author":"N Wang","year":"2020","unstructured":"Wang, N. et al. Retrospective multicenter cohort study shows early interferon therapy is associated with favorable clinical responses in COVID-19 patients. Cell Host Microbe 28, 455\u2013464 (2020).","journal-title":"Cell Host Microbe"},{"key":"840_CR30","doi-asserted-by":"publisher","first-page":"11620","DOI":"10.1128\/JVI.00702-07","volume":"81","author":"MG Wathelet","year":"2007","unstructured":"Wathelet, M. G., Orr, M., Frieman, M. B. & Baric, R. S. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. J. Virol. 81, 11620\u201311633 (2007).","journal-title":"J. Virol."},{"key":"840_CR31","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JVI.01782-06","volume":"81","author":"SA Kopecky-Bromberg","year":"2007","unstructured":"Kopecky-Bromberg, S. A., Mart\u00ednez-Sobrido, L., Frieman, M., Baric, R. A. & Palese, P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J. Virol. 81, 548\u2013557 (2007).","journal-title":"J. Virol."},{"key":"840_CR32","doi-asserted-by":"publisher","first-page":"e00319","DOI":"10.1128\/mBio.00319-19","volume":"10","author":"CE Comar","year":"2019","unstructured":"Comar, C. E. et al. Antagonism of dsRNA-induced innate immune pathways by NS4a and NS4b accessory proteins during MERS coronavirus infection. Mbio 10, e00319 (2019).","journal-title":"Mbio"},{"key":"840_CR33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/S1473-3099(20)30232-2","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect. Dis. 20, 656\u2013657 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"840_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41591-020-0869-5","volume":"26","author":"X He","year":"2020","unstructured":"He, X. et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat. Med. 26, 672\u2013675 (2020).","journal-title":"Nat. Med."},{"key":"840_CR35","doi-asserted-by":"crossref","unstructured":"National Health Commission & National Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Chin. Med. J. (Engl.) 133, 1087\u20131095 (2020).","DOI":"10.1097\/CM9.0000000000000819"},{"key":"840_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/cid\/ciy874","volume":"68","author":"TM Uyeki","year":"2019","unstructured":"Uyeki, T. M. et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin. Infect. Dis. 68, 895\u2013902 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"840_CR37","first-page":"2000045","volume":"25","author":"VM Corman","year":"2020","unstructured":"Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eur. Surveill. 25, 2000045 (2020).","journal-title":"Eur. Surveill."},{"key":"840_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41590-020-00840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-020-00840-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-020-00840-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:53:24Z","timestamp":1684605204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-020-00840-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["840"],"URL":"https:\/\/doi.org\/10.1038\/s41590-020-00840-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.21.20179291","asserted-by":"object"}]},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}